VIDEO

FindCenter AddIcon

Robin Carhart-Harris - Psychedelic Drugs in Science and Medicine

By Robin Carhart-Harris — 2015

New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression. See more...

54:19 min

01:09:33

Psychedelics Impact on Society | Rick Doblin, Ph.D. | Talks at Google

Rick Doblin - "Psychedelics: Mystical Experiences, Cultural Evolution, Non-Profit MDMA/PTSD Research, and Burning Man" Rick Doblin, the co-founder and CEO of the Multidisciplinary Association for Psychedelic Studies (MAPS, www.maps.

FindCenter AddIcon
06:48

Effects of Dose on Psilocybin Mystical Experiences and ‘Bad Trips’ | Roland Griffiths

FindCenter AddIcon
01:01:21

Psychedelics: Treating Addiction, Depression and Anxiety with Dr. Roland Griffiths

Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.

FindCenter AddIcon
01:15:24

Roland Griffiths, Ph.D. on Psilocybin, Psychedelic Therapies & Mystical Experiences

Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.

FindCenter AddIcon
30:33

Dr. Robin Carhart-Harris - the Science of Psychedelics with Magic Mushrooms

Head of Psychedelic Research, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Dr. Robin Carhart-Harris share today with us his knowledge and wisdom as a scientist about the magic mushrooms.

FindCenter AddIcon
17:18

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

FindCenter AddIcon
34:30

Amanda Feilding: LSD, Precious Key of Neuroscience | The Beckley Foundation

The Beckley Foundation Scientific Program conducts cutting edge research with LSD in human subjects, explores neurophysiological similarities between LSD and the mystical experience through observing modulations in the blood supply, brainwaves and a broad spectrum of cognitive changes.

FindCenter AddIcon
24:21

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research

Psychedelics afford a unique opportunity to expand our understanding of consciousness and its altered states, to develop techniques for enhancing consciousness, and to uncover new avenues of treatment and improved therapeutic techniques.

FindCenter AddIcon
01:11:17

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

FindCenter AddIcon
01:02:06

James Fadiman & Sophia Korb: Microdosing - the Phenomenon, Research Results & Startling Surprises

A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research